Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Palt

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Bioengineering and Biotechnology|December 21, 2023
Codon optimization regulates IgG3 and IgM expression and glycosylation in <i>N. benthamiana</i>Lin Sun, Somanath Kallolimath, Roman Palt, et al.
Plant Biotechnology Journal|November 20, 2022
A novel plant-made monoclonal antibody enhances the synergetic potency of an antibody cocktail against the SARS-CoV-2 Omicron variantCollin Jugler, Haiyan Sun, Katherine Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2021
Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgGLin Sun, Somanath Kallolimath, Roman Palt, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 2, 2021
Highly active engineered IgG3 antibodies against SARS-CoV-2Somanath Kallolimath, Lin Sun, Roman Palt, et al.
Antibodies (Basel, Switzerland)|June 25, 2025
Light Chain Isotype and Antibody-Specificity Impact on Virus NeutralizationLin Sun, Roman Palt, Georg Schütz, et al.
Frontiers in Immunology|June 26, 2023
Glyco engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologuesSomanath Kallolimath, Roman Palt, Esther Föderl-Höbenreich, et al.
Plant Biotechnology Journal|August 9, 2023
In planta expression of active bacterial GDP-6-deoxy-d-lyxo-4-hexulose reductase for glycan modulationBenjamin Kogelmann, Roman Palt, Daniel Maresch, et al.
Frontiers in Immunology|November 8, 2024
IgG1 versus IgG3: influence of antibody-specificity and allotypic variance on virus neutralization efficacySomanath Kallolimath, Lin Sun, Roman Palt, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Bioengineering and Biotechnology|December 21, 2023
Codon optimization regulates IgG3 and IgM expression and glycosylation in <i>N. benthamiana</i>Lin Sun, Somanath Kallolimath, Roman Palt, et al.
Plant Biotechnology Journal|November 20, 2022
A novel plant-made monoclonal antibody enhances the synergetic potency of an antibody cocktail against the SARS-CoV-2 Omicron variantCollin Jugler, Haiyan Sun, Katherine Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2021
Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgGLin Sun, Somanath Kallolimath, Roman Palt, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 2, 2021
Highly active engineered IgG3 antibodies against SARS-CoV-2Somanath Kallolimath, Lin Sun, Roman Palt, et al.
Antibodies (Basel, Switzerland)|June 25, 2025
Light Chain Isotype and Antibody-Specificity Impact on Virus NeutralizationLin Sun, Roman Palt, Georg Schütz, et al.
Frontiers in Immunology|June 26, 2023
Glyco engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologuesSomanath Kallolimath, Roman Palt, Esther Föderl-Höbenreich, et al.
Plant Biotechnology Journal|August 9, 2023
In planta expression of active bacterial GDP-6-deoxy-d-lyxo-4-hexulose reductase for glycan modulationBenjamin Kogelmann, Roman Palt, Daniel Maresch, et al.
Frontiers in Immunology|November 8, 2024
IgG1 versus IgG3: influence of antibody-specificity and allotypic variance on virus neutralization efficacySomanath Kallolimath, Lin Sun, Roman Palt, et al.
Pageof 1